Riskpilot← Back to searchSign inGet full accessSaga Terapi AB
ABActiveOrg 5566572516Månvägen 11Business and other management consultancy activities · NACE 7020Est. 20041 employees
Revenue 2025
SEK -1
-100% vs 2024
EBITDA margin
2240100.0%
-16% vs 2024
Equity ratio
92.0%
Financial strength
Net profit 2025
SEK -22K
-18% vs 2024
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -22K | -16% |
| Net profit | SEK -22K | -18% |
| Total assets | SEK 108K | -20% |
| Equity | SEK 99K | -18% |
| Employees | 1 | — |
Legal name
Saga Terapi AB
Org number
5566572516
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
8 mars 2004
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets verksamhet är att bedriva konsultation, coaching, samtalsterapi, mentorskap, utbildning, föreläsningar, kurser och utveckling inom områdena personlig utveckling, ledarskap, organisation, kommunikation, media och därmed förenlig verksamhet samt äga och förvalta fast och lös egendom jämte därmed förenlig verksamhet.
Address
Månvägen 11
Email
catharina.schott@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 192 | 64 | 128 | 96 | 32 | −0 |
| Staff expenses | — | — | — | — | — | — | −117 | −89 | −30 | −0 |
| EBITDA | −106 | −56 | −4 | −6 | 160 | −56 | −11 | −16 | −19 | −22 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — | — |
| EBIT | −106 | −56 | −4 | −6 | 160 | −56 | −11 | −16 | −19 | −22 |
| Net financials | — | — | — | — | — | — | −0 | 0 | 1 | 0 |
| Profit before tax | −7 | −56 | −4 | −6 | 122 | −18 | −11 | −16 | −19 | −22 |
| Tax | −7 | −0 | −0 | −0 | −25 | −0 | — | — | — | — |
| Net profit | −14 | −56 | −4 | −6 | 97 | −18 | −11 | −16 | −19 | −22 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 194 | 102 | 93 | 87 | 318 | 203 | 192 | 168 | 134 | 108 |
| Equity | 153 | 97 | 93 | 87 | 185 | 167 | 156 | 140 | 121 | 99 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Short-term debt | 41 | 5 | 0 | 0 | 95 | 36 | 37 | 29 | 13 | 9 |
| Total debt | 41 | 5 | — | — | 95 | 36 | 37 | 29 | 13 | 9 |
EBITDA margin
-2240100.0%
This company
15.8%
Market median
-14177948% vs market
20162025
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
20162025
Return on equity
-22.1%
This company
18.4%
Market median
-220% vs market
20162025
Net profit margin
-2192900.0%
This company
8.1%
Market median
-27072940% vs market
20162025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Saga Terapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Gustav Schött | Deputy Board Member | 0 companies |
| Anna Catharina Schött | Board of Directors | 0 companies |